Accordingly, targeting ER stress/IRE1α has been proposed as a direction for the improvement of insulin resistance in obesity and diabetes (Hetz et al., 2013; Marciniak et al., 2022). The gene discussed is ERN1; the disease is obesity due to melanocortin 4 receptor deficiency.